2nd Mastering HR Summit 2011

26 - 27 October 2011, Amsterdam, Netherlands.
North West Business GroupNorth West Business Group invites to attend the 2nd Mastering HR 2011 Conference, geared towards Vice Presidents, Directors, and Managers involved in Talent, recruitment and compensation and benefits. Based on the success of the previous Mastering HR conference in March 2011, the hot topics for a one-stop shop approach to international HR issues have been combined.

Driven by increasing recognition of the importance of human capital in today's competitive market, the organization's expectation of HR is continuously getting higher. The role of HR is evolving from an operational department to a strategic one. HR professionals need to advance their skills and equip the team with new and ever-changing ideas. Attending this exclusive conference will bring together top experts from across Europe for a very intensive and interactive meeting. Benefit from the hands-on approach and unique case studies from top players in the industry. This forum sets a platform for practitioners from around the world to discuss and share strategies for their future success.

The event will focus on the most current topics in the HR industry such as:

  • A Cohesive Approach to Recruiting, Hiring and Accelerating Talent
  • Utilizing Social Media to Reach Specific Skill Set Employees
  • Evaluating Current Trends In Recruitment And Retention
  • How Connecting Performance Management And Talent is going to help you?
  • Using Talent Development Programs As A Vehicle For The Corporate Strategy
  • Recruiting the Best Talent By Selling More Than Just A Salary - The Role Of Culture
  • Effective Remuneration Planning To Succeed In a Tight Labour Market
  • Effectively Communicating Remuneration And Benefits To Employees
  • How Recognition and Reward Can Motivate Employees to Build and Deliver Authentic Brand Experiences

Joins some of the experts like:

  • Genzyme, Vice President HR - European Commercial, CDMA
  • TeliaSonera, Vice President & HR Business Partner
  • Santander, Head of Talent Development & Performance
  • SAP, Director Learning & Talent Management
  • KPN, HR Director
  • IBM HR, Director Benelux
  • Astellas Pharma, Director Human Resources
  • Accenture, Country Director HR
  • Pfizer, Talent Acquisition COE Lead
  • Heinz, Director Compensation & Benefits
  • Zurich Financial Services, UK Head of Resourcing
  • IBM, Workforce Partner Benelux
  • UBS, HR Executive Director
  • Magnate Global Group MGG, Group CHRO
  • European Personnel Selection Office, Director of EPSO
  • IBM HR, Director Benelux
  • And many more ...

Who should attend?
This conference is designed to attract key decision makers from the HR industry with key job titles including: Managing Directors, Country Managers, General Managers, Vice Presidents, Regional Directors/Heads, Directors, Department Heads, Managers, etc.

Benefits of attending include:

  • Hearing from experts actively working in the industry
  • Participating in the panel discussions
  • Quizzing industry experts on the ideas that worked
  • Exchanging ideas with senior professionals across Europe

For further information and registration, please visit:
http://www.nwbg.eu/all-events/2nd-master-hr-sumit-2011/

Most Popular Now

BioNTech's statement on patent infringement lawsui…

BioNTech SE (Nasdaq: BNTX, "BioNTech") published an official statment: "BioNTech is aware of reports that Moderna has sued Pfizer and BioNTech, alleging that COMIRNATY® i...

Xenpozyme™ (olipudase alfa-rpcp) approved by FDA a…

The U.S. Food and Drug Administration (FDA) has approved Xenpozyme™ (olipudase alfa-rpcp) for the treatment of non-central nervous system (non-CNS) manifestations of acid...

FDA grants Breakthrough Therapy Designation to Pfi…

Pfizer Inc. (NYSE:PFE) today announced that its investigational Group B Streptococcus (GBS) vaccine candidate, GBS6 or PF-06760805, received Breakthrough Therapy Designat...

Malaria booster vaccine shows durable high efficac…

Researchers from the University of Oxford and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of ...

Research reveals widespread use of ineffective COV…

Monoclonal antibodies are laboratory-designed treatments tailor-made to fight specific infections. In early 2021, the U.S. Food & Drug Administration issued emergency use...

Efficacy, cash and more will increase booster shot…

The more effective the COVID-19 booster, the more likely people are to get it, according to new Cornell research. And they are more likely to accept the booster shot with...

Strict COVID lockdowns in France improved cardiova…

A new paper in European Heart Journal - Digital Health, published by Oxford University Press, indicates that social-distancing measures like total lockdown have a measura...

U.S. clinical trial evaluating antiviral for monke…

A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States. St...

Stem cell-gene therapy shows promise in ALS safety…

Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier. This...

Novartis invests in early technical development ca…

Novartis today announced it is investing in next-generation biotherapeutics with the creation of a fully integrated, dedicated USD 300m scientific environment that will b...

Drug turns cancer gene into "eat me" fla…

Tumor cells are notoriously good at evading the human immune system; they put up physical walls, wear disguises and handcuff the immune system with molecular tricks. Now...

Mucosal antibodies in the airways protect against …

High levels of mucosal antibodies in the airways reduce the risk of being infected by omicron, but many do not receive detectable antibodies in the airways despite three ...